Generation of de novo protein specific ligands

91 - Bioinfo-Proteomique

Service description

This technology allows the de novo generation of artificial protein ligands to identify a target of interest. The use of protein ligands is a stable and simple alternative to the production of monoclonal antibodies that do not present a risk of post-translational modifications. The methodology combines ribosome display, next-generation sequencing, and bioinformatics technologies. The production of ligands in E. coli is reproducible, inexpensive, and GMP-compatible.

Materials to provide

  • Sample sequence if known

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Determination of binder with high affinity against the target of interest
  • Identification of binder sequences
  • Study following the specifications validated with the Expert

Get started with your protein-specific new ligand generation project

Please answer the fields below to be contacted by our team of scientists